Measles vaccination in MSF context: priorities, results and challenges/concerns AFRICAN REGIONAL MEASLES-RUBELLA TAG MEETING Nairobi, June 2nd-3rd 2015.

Slides:



Advertisements
Similar presentations
Polio Communication Indicators Reflections from Polio Communication TAG/Review Process.
Advertisements

TFI recommendation for communication Polio/EPI Results from the follow-up consultation on Polio/EPI indicators Paryss Kouta, UNICEF WCARO Dakar - Senegal,
Global Measles and Rubella Strategic Plan
1 June 2011 Measles update- India Dr. Satish Kumar Gupta Health Specialist UNICEF- India 13 th September 2011.
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Measles Outbreaks in Southern Africa in 2010 Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
Any of the following risk factors within 3 weeks (21 days) before onset of symptoms 1,2 : Contact with blood or other body fluids of a patient known to.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
Presented by: Wosen Gezahegn, Amref Health Africa- Ethiopia
Ebola Virus Disease (EVD) Updated 11:30 a.m
Funded by Ebola: How can we help? Experiences from Sierra Leone Third Global Symposium on Health Systems Research Cape Town, 1 st October 2014.
Challenges in Measles Outbreak Responses MSF Perspectives Florence Fermon - Myriam Henkens 10th Annual Measles Initiative Meeting 14/09/2011.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Ebola Facts October 15, 2014.
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Management Response to the Annual Report on the Evaluation Function in UN Women in 2014.
Supporting Routine AND Supplementary Immunization Activities in STOP.
Plan of Action to improve injection Safety Within the EPI.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Invalid MCV1 doses – how big a problem? B Masresha WHO AFRO AFR MR TAG Meeting Nairobi, June 2015.
National Public Health Performance Standards Local Assessment Instrument Essential Service:3 Inform, Educate, and Empower People about Health Issues.
Health Cluster Response Plan CAP 2013 SANA”A, YEMEN October 20 th, 2012.
The Reaching Every District (RED) strategy.  Re-establish outreach services  Conduct supportive supervision  Establish community links with service.
Pan American Health Organization.. Protecting the Health of Health Care Workers: Experience from the Americas Marie-Claude Lavoie Decision Making for Using.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
What is “Reaching Every District” (RED) in Immunization? A brief overview Information from the global immunization partnership presented by Lora Shimp.
Roadmap Progress Report 2011 Zambia SARN-RBM PARTNERS ANNUAL CONSULTATIVE MEETING, JULY 2011.
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
Latest WHO Update (22 Sept. 2014) Estimates 20k cases by 2 Nov. CDC says 1.4 M by Jan. 20 Up to 70% fatality rate Ages 14 – 44, older are most fatal Most.
Health Security and Emergencies Ebola Response 13 October 2014.
First National Course on Public Health Emergency Management 12 – 23 March Muscat, Oman.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
MEASLES AND RUBELLA INITIATIVE Presentation by : Sylvia Khamati. Health Advisor Kenya Red Cross Society “Story from the Field” 15 th September 2015 American.
Measles pre-elimination in the African Region. Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
Regional measles elimination program updates B Masresha WHO AFRO AFR MR TAG Meeting Nairobi, June 2015.
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
EBOLA VIRUS DISEASE PREPAREDNESS Screening, Detection & Planning.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Inter-agency Global Evaluation of RH Services for Refugees and IDPs Component 4 Part B: Assessment of the Minimum Initial Service Package (MISP) of Reproductive.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Lutte contre l’infection : leçons à retenir dans le contexte de l’épidémie Ebola 26 Novembre eme Journée Romande d’Hygiène Hospitalière Dr Constanza.
Ebola preparedness and Response in Lao PDR. Outline Objective The preparedness contingency plan Phase 1: Preparedness Phase 2: Contingency for response.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
Coordination with health service providers and local authorities Module 3 Session 3.3 National Disaster Management Practitioners, Islamabad, Pakistan.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
Liberia Field Epidemiology Training Programme (LFETP)Liberia Field Epidemiology Training Programme LFETP) FIELD WORK 2 -Expanded Surveillance Report- -Measles.
PROGRESS TOWARDS MEASLES & RUBELLA ELIMINATION EXPERIENCE FROM OMAN SALAH AL AWAIDY, MD COMMUNICABLE DISEASES ADVISOR MOH, OMAN
Community Mobilization in Emergencies Use of Community Action Cycle Model to Improve Maternal and Child Health in South Sudan Michael Odong 1 ; Morris.
EBOLA OUTBREAK – LIBERIA, Current Status Scale and evolution of outbreak outpacing strategy and plans – 14 of 15 counties now affected – Major urban.
Global Measles and Rubella: Highlights, Priorities and Critical Issues
Response to the Yellow Fever Outbreak in the WHO African Region: What has been done? Dr Ambrose Talisuna, WHO-Regional Office for Africa-AFRO Brazzaville-Congo.
  Presented by: Rev. John B. Sumo, MA, MTh, MPH
WHO AFRO Technical Coordinator for Health Emergencies
World Health Organization
National health policy review
Content Public Health Emergencies Ebola Virus Disease: DRC
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
Content Public Health Emergencies Ebola Virus Disease: DRC
Epidemiological Update on Public Health Emergencies
African Region- priorities to reach the 2020 measles elimination goal.
Content Public Health Emergencies Ebola Virus Disease: DRC
Ebola Facts October 15, 2014.
YELLOW FEVER VACCINE AVAILABILITY AND NEEDS FOR THE AFRICAN REGION
Root Cause Analysis Identifying critical campaign challenges and diagnosing bottlenecks.
Presentation transcript:

Measles vaccination in MSF context: priorities, results and challenges/concerns AFRICAN REGIONAL MEASLES-RUBELLA TAG MEETING Nairobi, June 2nd-3rd 2015 Florence Fermon & Aitana Juan Photographs by Phil Moore, DRC, 2014

Outline MSF vaccination activities Measles outbreak response activities Vaccination in humanitarian emergencies Vaccination in Ebola affected countries Overview of the presentation

MSF and vaccination MSF projects in 2013: 66 countries, 387 projects, 215 (55%) in unstable contexts Expenses: €612 M (± 90% funding private, non-governmental sources) Vaccination policy clearly established in 2007 Priority countries to strengthen routine immunization Outbreak response Preventive vaccination campaigns: – Reduce risk of outbreaks in high risk areas – Preventive vaccination in emergencies 1 1 SAGE Working Group on Vaccination in Humanitarian Emergencies. Vaccination in acute humanitarian emergencies: a framework for decision making. IVB WHO, October 2013

Doses routine vaccination * Doses in response to epidemics Doses preventive campaigns Doses post-exposure prophylaxis Total doses administered Evolution of MSF vaccination activities, Overview of MSF vaccination activities * Incomplete reporting routine vaccination for 2014

MSF supply of vaccines

Despite routine and SIAs activities, we are facing an excessive number of outbreaks MSF measles outbreak responses

Outbreak responses 2015: 20 measles outbreak response interventions + other going on Sudan, DRC, CAR, Chad

Outbreak in 11 districts Response campaigns: – conducted in 6 of 11 districts in outbreak – targeting different age groups SIAs conducted in 2012 and October 2014 April 2015 – 637 suspected measles cases reported – 15 deaths reported – 52% of confirmed cases >15 years of age Measles outbreak in Chad: an unexpected situation? WHO AFR Measles weekly partner updates. May, 2015

: – increase in the number of cases from south to north – Several ORI conducted by MSF and MoH SIAs conducted in 2014 Measles outbreak in DRC Mancini et al. Description of a large measles epidemic in Democratic Republic of Congo, Conflict and Health 2014, 8:9

May 2015: – 11,657 measles cases reported – 134 measles deaths reported – 19 zones de santé affected with 261 districts Mid June – Extension to other areas Measles outbreak in DRC: a repetitive situation? WHO AFR Measles weekly partner updates. May, 2015

How could the quality of vaccination activities be improved? Are age group tailored to the specific context? Is EPI able to ensure a basic protection? – Limited window to vaccinate: 9-11 months – Catch-up not clearly mentioned in EPI policy Are intervals between campaigns adapted following a systematic risk analysis? Is there enough flexibility to implement context-specific strategies? Are decisions possible at district level? Is MRI fund for ORI known and used as required? Why measles outbreaks remain so frequent in some countries?

Preventive vaccination in humanitarian emergencies Measles vaccination is one of first 10 priorities in emergency situations New WHO recommendations for extended vaccination package according to risk evaluation

Preventive vaccination in emergencies Measles quickly implemented, but insufficient follow-up over time Lack of awareness of new WHO recommendations leading to long negotiations and delay in implementation Cost and availability of some vaccines There is need of appropriation and support from HQ and regional offices of UN agencies and partners

Measles vaccination in Ebola affected countries A new challenge

2 countries: Liberia and Sierra Leone Pilot innovative and context adapted vaccination campaign for measles Test strategies: door to door and fixed sites, in rural and urban setting Analyse the outcomes and share/discuss results on the feasibility of mass vaccination in an EVD context with possibly different approaches Collaborate with MoHS and partners MSF operational proposals in Ebola affected countries

Main strategic points Training of staff Strong supervision Specific Ebola triage Adapted IPC measures Use of retractable needles + safety container Complete micro-planning with specific attention to “at risk and hard to reach populations” Vaccination teams performance expected children per day per fixed-site team Follow up of post-vaccination fever Health Promotion and advocacy activities, important component of the project (pre and post-vaccination)

IPC measures Don’t touch policy Hand washing points 0.05% chorine (staff, parents and children) Accidental exposure protocol in place and known by staff Waste management: secure collection and burning Triage Case investigation area, holding area and referral system Efficient crowd control measures and strict flow circuit: -≤ 10 children in the waiting area -≤ 3 people inside the vacci area

Personal protective equipment (PPE): – Triage/case investigation: scrubs/boots + face protection + gown + gloves – Vaccinators: scrubs/boots + gloves IPC measures (2)

Challenges vaccination in Ebola context Ebola uncertain evolution EPI should be re-established as soon as possible after the start of an epidemic, when training and specific procedures can be implemented Lack of expertise Lack of specific recommendations on best approaches Importance of implementing pilot projects (innovative, context adapted vaccination activities) Need of involvement of a multidisciplinary team, with advice from infection-control specialists

MSF main concerns on measles EPI is the base to guaranty and maintain efficient measles coverage but: – It requires clear written MCV1 policy to catch-up children >12 months if required – Strong ownership of UN agencies to support/implement flexibility out of the traditional target age group There is a need of better tailored, quality and evaluated SIAs Ebola situation highlight the need to: – Avoid long break in EPI – Ensure safety protection measures for patients and staff – Communication and social mobilization

Thank you